Tag: AAPL

Blue Horseshoe Stocks: PBR, ACHN, TMSH & More

Petroleo Brasiliero S.A. (Petrobras) PBR

We’ll kick things off this morning with PBR once again, as the stock had another banner day and behaved very much like we suggested it might. Yesterday we mentioned that the PBR chart was looking ripe for further northward movement and that’s just what we got.

The stock itself broke back over $15, which led to some prime opportunities in each and every set of options contracts that we outlined in our morning report. We said we’d be looking at Weekly Calls from $14-$15 for quick-flip intraday opportunities, and they all offered up some serious gains.

The $14 Calls traded from .74 to as high as 1.09, a chance for traders to score up to 47% in profits. The $14.50’s made a nice move up from .34 to .75, good for a nice double-bagger and more at +120% The $15’s fared extremely well also, running a whopping 290% from .11 up to .43.

Even our contracts of longer-term interest, the 07/19 $15 Calls (which we caught at a low of .25) made a solid intraday move from .54-.84, a highly respectable 55% increase.

All in all, for options traders, PBR was a paradise on Monday, and we’ll be continuously monitoring the situation as the week progresses. Major areas of resistance appear on the chart at 15.50 and 15.85, so failure to pierce through that channel would certainly be a signal to us to take profits off of the table. In order to keep our interest levels high, PBR will need to maintain support above the 15-dollar mark.

Achillion Pharmaceuticals, Inc. ACHN

Appearing in yesterday’s extended watchlist, ACHN was another play with potential to start off a new week. After a significant morning gap-up, the stock would touch a low of 3.72 before running as high as 4.82, an intraday move of 30%

This morning the company came with a well-timed release concerning its Hep-C drug, and the stock continues to blow its top. The high this morning in premarket trading is 6.47, making ACHN one that we’ll definitely be interested to follow. Per this morning’s PR, there’s a timeline for the testing of this drug leading all the way up to the end of the year, so we’ll stick ACHN on our longer-term radar as well.

NEW HAVEN, Jun 10, 2014 (GLOBE NEWSWIRE via COMTEX) — Initial cohort of HCV-infected patients begin dosing with ACH-3422 for seven days. Clinical trials may continue evaluating 200 mg of sovaprevir for HCV-infected patients. Timelines for reporting proof-of-concept results with ACH-3422, a proprietary uridine-analog nucleotide polymerase inhibitor, during the fall of 2014 and initiating all-oral combination studies by the end of 2014 remain on track >>> FULL PR

TransGlobal Assets, Inc. TMSH

We’ve been following TMSH since last week, and have not been disappointed. The stock has played out a textbook dip-and-rip scenario for the last three sessions straight, offering up many opportunities to make gains.

Yesterday, it came down as low as .0079 before ripping its way up to .0128, a healthy intraday increase of 62% Provided it continues to trade in this manner, we’ll be looking to take advantage of any similar swings to the ones we’ve seen already. We want to see it make higher lows, and break through the channel of resistance between the previous two sessions’ swing highs (.0128-.0139).

Side Note:

Even with so much else to talk about today, we can’t forget about another cash cow in Apple. AAPL Calls have been providing us with some excellent opportunities in recent weeks as well, and we’re still highly attuned to that situation as well.

Extended Watchlist:
DNAX, SPEX, AVNR, SGMS, ATEA, TPLM, KNDI

Blue Horseshoe Stocks: AAPL, TMSH

Apple, Inc. AAPL

AAPL has been very good to us recently as the stock pushes ever-higher. The last (and only) time AAPL has ever been this highly valued was back in late 2012. We’ve squeezed a lot of life out of AAPL Calls, and should the current trend continue, this may only be the beginning.

During yesterday’s session AAPL surged as high as 649.3699, just shy of a big psychological barrier.  If we can see a break of that $650-mark, we could easily see another 10-point day from Apple. Failure to crack through that mark may result in a consolidation, but nothing of what we’ve seen from this stock lately suggests that the party’s over.

We’ve still got our eyes on the Call side of the options chain as we cruise into the weekend; and as you know, AAPL will undergo a 7-for-1 forward split effective on Monday, greatly increasing its number of shares. It is thought that the calculated move will make the stock accessible to more investors, and we expect AAPL to be trading just under $100 following the split, so that could very well be the case.

We’ll see where it lands, and our strategies will be very much the same as they are now, just at lower prices. We also have the launch of the new iPhone to look forward to, although there’s no concrete date on that yet. Speculation over its new features is something we expect to continue driving up the stock’s value until the product is launched.

All in all, this summer could be a big one for Apple, and we’ll be following along every step of the way, using options to leverage big gains for ourselves as we’ve done so many times in the past.

TransGlobal Assets, Inc. TMSH

On Wednesday, we tagged TMSH in our extended watchlist, and we were glad to have done so. The stock has provided us with a nice 50% move from .006-.009 this week. As you can see on the chart below, there are a lot of positives, including an impending golden cross, so we’re still going to be very interested to see what can happen with this play moving forward.

The key resistance area is yesterday high at the .009-mark, and a break of that level would send us into Blue Sky Breakout mode, so we want to keep a close watch on TMSH heading into next week.

Extended Watchlist:
RMGN, NIHD, BDSI, HKTV, FRO

Blue Horseshoe Stocks: VNDA, NQ & More

NQ Mobile, Inc. NQ

Yesterday, we pointed out all the reasons why we felt that NQ was in a good position to make a run, and we certainly hope folks took it to heart, because the stock followed it up with an solid session.

We first observed a morning low of 9.40, and NQ subsequently made a healthy move to a high of 10.85 on the afternoon, which was good for an intraday gain of 15%

On the options side of things, the $10 Calls dipped as low as .35, and went on to trade as high as a 1.00. This provides a good example of why we’ve gotten more and more into trading options on big board plays. Even just a modest move on the chart can translate into huge gains on the right contracts.

NQ is gapping up to the tune of another 5% this morning, so we’ll continue to keep an eye on things as we head into week’s end.

So far, from the low we observed following our tag of NQ toward the end of last month (6.25) we’ve seen gains on the order of 77%

Vanda Pharmaceuticals, Inc. VNDA

VNDA was another NASDAQ-listed stock that appeared in yesterday’s report on the Extended Watchlist. It would trade in a range from 11.00-12.99, an 18% increase. Another modest move compared to what we’re accustomed to with the pennies, but coming from a big board play, 18% in a single afternoon is very impressive.

Like NQ, VNDA was trading near a relative bottom when we passed it along to readers, and with this new-found momentum, it will be interesting to see what happens next.

Whether or not VNDA can crack through its 50DMA (13.04) is going to be the deciding factor as to whether there’s more upside here. Yesterday’s high came in just shy of that mark, so we’ve got some resistance to contend with, but we’ll certainly be monitoring very closely for a break of that level on the chart.

Shamika 2 Gold, Inc. SHMX

SHMX is a sub-penny breakout play that we want to add to our radar this morning. Yesterday the stock traded 9x its 3-month average volume, and traded in a range from .0003-.0006. It always a good idea to be cautious when dealing with these triple-zero stocks, but as most of you know, when the potential risk is high, the potential rewards can be even higher.

We’re going to monitor this play for further activity, more specifically, a potential dip-and-rip. Should SHMX taper off and pull back, that’s where we’ll be waiting to strike. Correctly timing the bottom on one of these super–subpenny stocks can treat traders to a heck of a bounceplay as we’ve seen so many times in the past.


Side Note: AAPL Options

AAPL continued to break out yesterday past last week’s swing high of 644.17. Remember, on Monday we reminded everyone that the AAPL options chain was a good candidate to provide us with opportunities over the course of the week, and that has certainly been true thus far.  The $640 Calls were as cheap as 1.35 on that day, and by yesterday, they were going for as much as 9.50.

Huge moves like that have almost become commonplace, as we’ve tracked AAPL through a more-than 100-dollar increase in just the past couple of months.

Extended Watchlist:
NEWL, S, HALO, AXAS, GIGA, BBRY